BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 11240231)

  • 1. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
    Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
    World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
    Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
    Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
    Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
    Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
    Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function.
    Braaksma MM; Wijers OB; van Sörnsen de Koste JR; van der Est H; Schmitz PI; Nowak PJ; Levendag PC
    Radiother Oncol; 2003 Mar; 66(3):291-302. PubMed ID: 12742269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer.
    Chao KS
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):20-5. PubMed ID: 11917280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.
    Henson BS; Inglehart MR; Eisbruch A; Ship JA
    Oral Oncol; 2001 Jan; 37(1):84-93. PubMed ID: 11120488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy.
    Lal P; Nautiyal V; Verma M; Yadav R; Maria Das KJ; Kumar S
    J Cancer Res Ther; 2018; 14(6):1196-1201. PubMed ID: 30488829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients.
    Malouf JG; Aragon C; Henson BS; Eisbruch A; Ship JA
    Cancer Detect Prev; 2003; 27(4):305-10. PubMed ID: 12893079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results.
    Ship JA; Eisbruch A; D'Hondt E; Jones RE
    J Dent Res; 1997 Mar; 76(3):807-13. PubMed ID: 9109831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing Xerostomia by Comprehensive Protection of Salivary Glands in Intensity-Modulated Radiation Therapy with Helical Tomotherapy Technique for Head-and-Neck Cancer Patients: A Prospective Observational Study.
    Teng F; Fan W; Luo Y; Ju Z; Gong H; Ge R; Tong F; Zhang X; Ma L
    Biomed Res Int; 2019; 2019():2401743. PubMed ID: 31380414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial irradiation of the parotid gland.
    Eisbruch A; Ship JA; Kim HM; Ten Haken RK
    Semin Radiat Oncol; 2001 Jul; 11(3):234-9. PubMed ID: 11447580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction.
    McDonald S; Meyerowitz C; Smudzin T; Rubin P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):747-54. PubMed ID: 8040020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.